Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience.
Shaheen HasmatJulie R HowleDeme J KarikiosMatteo S CarlinoMichael J VenessPublished in: Journal of medical imaging and radiation oncology (2021)
Consistent with clinical trial results, anti-PD-L1/PD1 therapy in this small series demonstrated efficacy and safety in patients with metastatic MCC.